Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 6
2008 3
2009 4
2010 6
2011 7
2012 3
2013 1
2014 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Pancreatic Cancer: Beyond Brca Mutations.
Ricci V, Fabozzi T, Bareschino MA, Barletta E, Germano D, Paciolla I, Tinessa V, Grimaldi AM. Ricci V, et al. Among authors: bareschino ma. J Pers Med. 2022 Dec 16;12(12):2076. doi: 10.3390/jpm12122076. J Pers Med. 2022. PMID: 36556296 Free PMC article. Review.
Erlotinib in cancer treatment.
Bareschino MA, Schettino C, Troiani T, Martinelli E, Morgillo F, Ciardiello F. Bareschino MA, et al. Ann Oncol. 2007 Jun;18 Suppl 6:vi35-41. doi: 10.1093/annonc/mdm222. Ann Oncol. 2007. PMID: 17591829 Free article. Review.
Non-small-cell lung carcinoma vaccines in clinical trials.
Rossi A, Maione P, Schettino C, Bareschino MA, Sacco PC, Ambrosio R, Barbato V, Zeppa R, Palazzolo G, Gridelli C. Rossi A, et al. Among authors: bareschino ma. Expert Rev Vaccines. 2011 Jun;10(6):887-97. doi: 10.1586/erv.11.16. Expert Rev Vaccines. 2011. PMID: 21692707 Review.
New molecular targets in the treatment of NSCLC.
Schettino C, Bareschino MA, Sacco PC, Maione P, Rossi A, Casaluce F, Sgambato A, Gridelli C. Schettino C, et al. Among authors: bareschino ma. Curr Pharm Des. 2013;19(30):5333-43. doi: 10.2174/13816128113199990343. Curr Pharm Des. 2013. PMID: 23394083 Review.
Advances in chemotherapy in advanced non-small-cell lung cancer.
Maione P, Rossi A, Sacco PC, Bareschino MA, Schettino C, Gridelli C. Maione P, et al. Among authors: bareschino ma. Expert Opin Pharmacother. 2010 Dec;11(18):2997-3007. doi: 10.1517/14656566.2010.511615. Epub 2010 Aug 12. Expert Opin Pharmacother. 2010. PMID: 20701554 Review.
Targeting angiogenesis for treatment of NSCLC brain metastases.
Schettino C, Bareschino MA, Rossi A, Maione P, Sacco PC, Colantuoni G, Rossi E, Gridelli C. Schettino C, et al. Among authors: bareschino ma. Curr Cancer Drug Targets. 2012 Mar;12(3):289-99. doi: 10.2174/156800912799277476. Curr Cancer Drug Targets. 2012. PMID: 22229249 Review.
Combination of standard chemotherapy and targeted agents.
Bareschino MA, Morgillo F, Ciardiello F. Bareschino MA, et al. J Thorac Oncol. 2007 May;2(5 Suppl):S19-23. doi: 10.1097/01.JTO.0000268636.02709.b4. J Thorac Oncol. 2007. PMID: 17457224 Free article. Review. No abstract available.
Pemetrexed in advanced non-small cell lung cancer.
Gridelli C, Maione P, Rossi A, Bareschino MA, Schettino C, Sacco PC, Zeppa R. Gridelli C, et al. Among authors: bareschino ma. Expert Opin Drug Saf. 2011 Mar;10(2):311-7. doi: 10.1517/14740338.2011.553281. Epub 2011 Jan 25. Expert Opin Drug Saf. 2011. PMID: 21261558 Review.
Irreversible EGFR inhibitors in the treatment of advanced NSCLC.
Maione P, Rossi A, Bareschino M, Sacco PC, Schettino C, Casaluce F, Sgambato A, Gridelli C. Maione P, et al. Among authors: bareschino m. Curr Pharm Des. 2014;20(24):3894-900. doi: 10.2174/13816128113196660764. Curr Pharm Des. 2014. PMID: 24138713 Review.
32 results